Company | Cboe Global Markets, Inc. |
Ticker | CBOE (Cboe BZX) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | July 31, 2026 (pre-market); conference call 7:30 a.m. CT / 8:30 a.m. ET |
Prepared | July 30, 2026 |
Last Earnings | May 1, 2026 (Q1 2026) |
Key Takeaway: Setup leans toward a beat — consensus has been revised sharply higher since Q1 and the macro backdrop (record industry options volumes, strong equity market activity) was broadly favorable in Q2, but the stock's sharp mid-quarter selloff and subsequent partial recovery suggest the market is pricing in meaningful uncertainty around the sustainability of Q1's record pace.
Heading into Q2 2026, the bar for CBOE is elevated but arguably achievable: consensus adjusted diluted EPS of $3.48 represents a ~41% year-over-year increase, and net revenue consensus of $721M implies continued double-digit growth off Q1's record $729M print. Management's tone coming out of Q1 was decidedly bullish — full-year organic revenue growth guidance was raised to low double-digit to mid-teens (from mid single-digit), and adjusted opex guidance was cut — signaling confidence in the structural demand for SPX options and Data Vantage. Estimate revisions have tracked guidance aggressively upward: the Q2 EPS consensus has risen from $3.30 at the post-Q1 baseline to $3.48 today, a ~5.5% upward move that leaves little room for disappointment. The stock, however, tells a more complicated story: CBOE surged to ~$366 in mid-May before a sharp ~33% drawdown to a trough near $231 in late June, driven by what appears to be a combination of multiple compression and concern that Q1's volatility-driven volumes were a one-time spike rather than a durable trend; the stock has since recovered to ~$297, still well below its post-Q1 highs. The key wildcard is SPX options ADV in Q2: peer commentary from Nasdaq (July 23) confirmed record industry options volumes and record derivatives contract volumes up 33% in Q2, which is a strong positive read-through, but MKTX's Q2 results flagged "lower market volatility" as a headwind — the net effect on CBOE's proprietary index options RPC and ADV will be the critical swing factor in the print.
Key Takeaway: Consensus is a moderately high bar — estimates have been revised up ~5–8% since Q1 earnings across key metrics. SPX index options ADV and RPC are the bigger swing factors; Data Vantage recurring revenue is the more predictable anchor.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY 2026 Guidance | Consensus vs. Guidance |
Net Revenue ($M) | $728.9M | $587.3M | $720.9M ¹ | +22.8% YoY | Low double-digit to mid-teens organic growth (FY) | Tracking within guidance range |
Adjusted Diluted EPS ($) | $3.70 | $2.46 | $3.48 ¹ | +41.5% YoY | No specific quarterly EPS guidance provided | N/A (no quarterly EPS guidance) |
Index Options ADV (K contracts) | 6,136K | 4,686K | 6,208K ¹ | +32.5% YoY | No specific quarterly ADV guidance | N/A |
Options Revenue Per Contract — RPC ($) | $0.343 | $0.300 | $0.317 ¹ | +5.7% YoY | No specific RPC guidance | N/A |
Options Net Revenue ($M) | $467.6M | $364.8M | $469.9M ¹ | +28.8% YoY | No specific segment guidance | N/A |
Data Vantage Net Revenue ($M) | $177.8M | $155.1M | $172.6M ¹ | +11.3% YoY | Low double-digit organic growth (FY) | Tracking within guidance range |
Adjusted Operating EBITDA ($M) | $544.6M | $382.3M | $521.8M ¹ | +36.5% YoY | Adj. opex $838–$853M (FY) | Consistent with guidance |
¹ Source: Visible Alpha Consensus and Actuals Data
Quarter | Reported | Consensus Est. | Surprise % | Result |
Q1 2026 | $3.70 | $3.40 | +8.8% | BEAT |
Q4 2025 | $3.06 | $2.96 | +3.4% | BEAT |
Q3 2025 | $2.67 | $2.53 | +5.5% | BEAT |
Q2 2025 | $2.46 | $2.44 | +0.8% | BEAT |
Q1 2025 | $2.50 | $2.37 | +5.5% | BEAT |
Q4 2024 | $2.10 | $2.11 | -0.5% | MISS |
Q3 2024 | $2.22 | $2.19 | +1.4% | BEAT |
Q2 2024 | $2.46 | $2.44 | +0.8% | BEAT |
Source: Visible Alpha Consensus and Actuals Data. Pattern: CBOE has beaten adjusted EPS consensus in 7 of the last 8 quarters, with the magnitude of beats accelerating sharply in recent quarters (Q1 2026: +8.8%, Q3 2025: +5.5%) — a consistent track record that supports a constructive setup, though the elevated bar post-Q1 raises the hurdle.
Quarter | Reported ADV | Consensus Est. | Surprise % | Result |
Q1 2026 | 6,136K | 6,136K | ~0.0% | IN LINE |
Q4 2025 | 5,454K | 5,454K | ~0.0% | IN LINE |
Q3 2025 | 4,864K | 4,864K | ~0.0% | IN LINE |
Q2 2025 | 4,686K | 4,686K | ~0.0% | IN LINE |
Q1 2025 | 4,771K | 4,764K | +0.1% | IN LINE / SLIGHT BEAT |
Q4 2024 | 4,040K | 4,040K | ~0.0% | IN LINE |
Q3 2024 | 4,227K | 4,202K | +0.6% | SLIGHT BEAT |
Q2 2024 | 4,686K | 4,686K | ~0.0% | IN LINE |
Source: Visible Alpha Consensus and Actuals Data. Pattern: Index options ADV has consistently tracked consensus closely (within ~1%), suggesting the sell-side models this metric well from publicly available monthly volume data. The Q2 2026 consensus of 6,208K implies continued strong growth; the key question is whether the macro-driven surge in non-0DTE options seen in March 2026 sustained into April–June.
Key Takeaway: Guidance was raised substantially at Q1 2026 earnings (May 1) and has not been formally revised since. No 8-K or conference update has changed the numbers. Management tone remains confident, with the strategic realignment (workforce reduction, Canada/Australia divestiture) proceeding on plan.
Metric | Initial Guidance (Q1 2026 Earnings Call — May 1, 2026) | Revised Guidance | Current Consensus | Note |
FY 2026 Organic Total Net Revenue Growth | Low double-digit to mid-teens (raised from mid single-digit at Q4 2025 earnings) | — | $2,858M FY consensus ¹ implies ~13–14% organic growth | No post-Q1 revision. Consensus tracking at high end of guidance range. |
FY 2026 Data Vantage Organic Growth | Low double-digit (raised from mid-to-high single-digit) | — | $700.8M FY consensus ¹ implies ~11–12% growth | No post-Q1 revision. Consensus at low end of guidance range. |
FY 2026 Adjusted Operating Expenses | $838–$853M (lowered from $864–$879M; includes ~$20–25M savings from incremental realignment) | — | N/A — not directly tracked in VA consensus | No post-Q1 revision. Annualized savings target raised to 12–14% vs. 2025 ($100–$120M total). |
FY 2026 CapEx | $73–$83M | — | N/A | Reaffirmed at Q1 2026 earnings. No change. |
FY 2026 D&A Expense | $56–$60M (excl. acquired intangibles amortization) | — | N/A | Reaffirmed at Q1 2026 earnings. No change. |
FY 2026 Effective Tax Rate (Adjusted) | 27.5–29.5% | — | N/A | Reaffirmed at Q1 2026 earnings. No change. |
Q2 2026 Net Interest Income | $3.5–$4.5M positive contributor (provided on Q1 call) | — | N/A | Only quarterly-specific guidance item provided. No revision. |
¹ Source: Visible Alpha Consensus and Actuals Data
Key Takeaway: Estimates have been revised sharply higher since Q1 earnings across all key metrics, tracking well above the post-Q4 baseline. The Q2 EPS consensus has risen ~5.5% since the post-Q1 baseline, and the FY 2026 EPS consensus is up ~1.8% — revisions are tracking with guidance, not diverging, which is a constructive signal. The gap between current consensus and guidance midpoints is narrow, leaving limited cushion if volumes disappoint.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 8, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 2026 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. Diluted EPS — Q2 2026 | $3.30 ¹ | $3.48 ¹ | +5.5% | No quarterly EPS guidance | No quarterly EPS guidance | N/A | N/A |
Adj. Diluted EPS — FY 2026 | $13.64 ¹ | $13.89 ¹ | +1.8% | No FY EPS guidance | No FY EPS guidance | N/A | N/A |
Net Revenue — Q2 2026 ($M) | $693.8M ¹ | $720.9M ¹ | +3.9% | Low double-digit to mid-teens organic growth (FY) | Unchanged | No change | Tracking within range |
Net Revenue — FY 2026 ($M) | $2,820.8M ¹ | $2,858.1M ¹ | +1.3% | Low double-digit to mid-teens organic growth | Unchanged | No change | Tracking at high end of range |
Index Options ADV — Q2 2026 (K) | 5,873K ¹ | 6,208K ¹ | +5.7% | No quarterly ADV guidance | No quarterly ADV guidance | N/A | N/A |
Data Vantage Revenue — FY 2026 ($M) | $699.5M ¹ | $700.8M ¹ | +0.2% | Low double-digit organic growth | Unchanged | No change | Tracking at low end of guidance range |
¹ Source: Visible Alpha Consensus and Actuals Data. As-of date May 8, 2026 used as post-Q1 earnings baseline (approximately 5 trading days after May 1, 2026 earnings release).
The most notable revision is in Q2 EPS (+5.5%) and Q2 net revenue (+3.9%), both driven by the market incorporating the strong Q1 momentum and favorable macro backdrop (elevated volatility, record industry options volumes) into Q2 estimates. Data Vantage FY estimates are essentially flat since Q1, consistent with the more predictable, subscription-like nature of that revenue stream.
Key Takeaway: CBOE dramatically underperformed both XLF and the S&P 500 since Q1 earnings, driven by a sharp mid-quarter selloff (peak ~$366 to trough ~$231, a ~37% drawdown) that appears to reflect multiple compression and concern about volume sustainability — not earnings revisions, which moved higher. The partial recovery to ~$297 suggests the market is not fully pricing in a repeat of Q1's record performance.
CBOE vs. XLF (Financial Select Sector SPDR ETF) vs. S&P 500 (SPY) — Indexed to 100 at May 1, 2026 (Q1 2026 Earnings Date). Source: Stock Price Data.
CBOE surged ~12% in the first two weeks post-Q1 earnings (to ~$366 by May 13), reflecting the record beat and dramatically raised guidance. However, the stock then reversed sharply, falling ~37% from peak to trough (~$231 on June 29), dramatically underperforming XLF (+3% over the same period) and SPY (roughly flat). The selloff appears driven by: (1) concern that Q1's volatility-driven volume surge was not repeatable in a calmer Q2 environment; (2) broader multiple compression as the stock had re-rated to a premium valuation; and (3) uncertainty around the strategic realignment (20% workforce reduction, Canada/Australia divestiture). The stock has since recovered to ~$297 as of July 30, still ~19% below its post-Q1 peak, suggesting the market is pricing in a more moderate Q2 print. XLF has been a strong outperformer over the period (+10%), reflecting the broader financial sector tailwind from rising rates and strong capital markets activity — CBOE's underperformance vs. XLF is notable and suggests company-specific concerns dominate.
Key Takeaway: The most important post-Q1 development is the July 24, 2026 refinancing of CBOE's revolving credit facility ($400M, 5-year), which signals financial flexibility and balance sheet confidence heading into the print. No guidance-changing events have occurred since Q1 earnings.
Key Takeaway: Peer commentary from the past 60 days is broadly constructive for CBOE's Q2 print. Nasdaq's Q2 2026 earnings (July 23) confirmed record industry options volumes and derivatives contract volumes up 33% YoY — the strongest direct read-through. ICE's Q2 results (July 30) confirmed record cash equities and strong derivatives open interest growth. The one cautionary note: MKTX's Q2 results flagged "lower market volatility" as a headwind to transaction revenues, which could weigh on CBOE's RPC.
Methodology note: Only commentary dated May 30 – July 30, 2026 that explicitly addresses Q2 2026 (April–June) activity or post-Q1 forward outlook is included below. Commentary limited to prior-quarter (Q1 2026) results without forward-looking content has been excluded.
Relevance: HIGHEST. Nasdaq is CBOE's closest peer in U.S. options and cash equities. Q2 2026 results directly confirm industry volume trends for the quarter CBOE is about to report.
Key Q2 2026 observations:
Read-through to CBOE: Strongly positive for SPX index options ADV and overall options net revenue. Record industry volumes and the June 18/26 event-driven spikes should have benefited CBOE's proprietary index options franchise directly. The mix-shift caveat (lower capture) is worth watching for CBOE's RPC, which consensus has at $0.317 vs. Q1's $0.343.
Relevance: HIGH. ICE operates NYSE (cash equities) and a broad derivatives franchise. Q2 2026 results confirm the macro environment and cash equities trends relevant to CBOE's North American Equities and European segments.
Key Q2 2026 observations:
Read-through to CBOE: Positive for cash equities (NYSE record +15% is a strong signal for CBOE's NA Equities segment) and market data. The "moderation in episodic volatility" comment is the key caveat — if Q2 was characterized by lower event-driven volatility, CBOE's VIX futures/options and non-0DTE SPX options could face headwinds vs. Q1's macro-driven surge. However, ICE's strong open interest growth (+20%) suggests structural demand for derivatives remains intact.
Relevance: MODERATE-HIGH. CME's equity complex and market data trends are relevant to CBOE, though CME's core business (interest rates, commodities, FX futures) is less directly comparable.
Key Q2 2026 observations:
Read-through to CBOE: Positive for equity derivatives demand (CME equity complex +13% YoY, June +54%) and market data (record $238M). The event contracts growth (ADV +40% QoQ) is particularly relevant as CBOE is pursuing its own event contract strategy — CME's traction validates the market opportunity. CME's single-stock futures launch is a potential competitive dynamic to watch for CBOE's options franchise, though CME management views these as complementary rather than cannibalistic.
Relevance: MODERATE. Conference commentary from Nasdaq President Tal Cohen provided real-time observations on April–May 2026 market activity, directly relevant to CBOE's Q2 reporting period.
Key Q2 2026 observations (April–May activity):
Read-through to CBOE: Positive for Q2 options volumes — the April–May observations confirm the favorable environment that should have supported CBOE's SPX franchise. The binary options competitive dynamic (Nasdaq targeting year-end launch) is a longer-term consideration, not a Q2 earnings driver.
Relevance: MODERATE. ICE COO Stuart Williams provided current-quarter observations on macro drivers and derivatives trends relevant to CBOE's Q2 environment.
Key Q2 2026 observations:
Read-through to CBOE: The macro backdrop described (geopolitical uncertainty, rate repricing, AI-driven data demand) is broadly supportive of CBOE's derivatives volumes and Data Vantage growth. The rate repricing dynamic (ECB rate hike in June) likely drove increased hedging demand that could benefit CBOE's European operations. Data center/colo demand growth is a positive read-through for CBOE's access and capacity fees.
Relevance: LOW-MODERATE. MKTX is a fixed income electronic trading platform — less directly comparable to CBOE's equity/options franchise, but provides a read on overall market activity and data/services demand.
Key Q2 2026 observations:
Read-through to CBOE: The "lower market volatility" characterization is the most important caveat for CBOE — if Q2 was indeed a lower-volatility quarter vs. Q1's macro-driven spike, CBOE's VIX-related products and non-0DTE SPX options could face headwinds. However, MKTX's strong services/data revenue growth (+14%) is a positive read-through for CBOE's Data Vantage segment. The fixed income volume decline is not directly applicable to CBOE's core equity options business.
Relevance: LOW-MODERATE. MKTX CEO provided May 2026 activity data and Q2 forward commentary.
Key Q2 2026 observations (May activity):
Read-through to CBOE: Record new issuance in fixed income suggests a healthy capital markets environment that could support equity market activity and options demand. Limited direct read-through to CBOE's core business.
Peer | Date | Key Signal for CBOE Q2 | Direction | Relevance |
NDAQ Q2 Earnings | Jul 23, 2026 | Record industry options volumes; derivatives contracts +33% YoY; record triple-witching & Russell recon | Positive | Highest |
ICE Q2 Earnings | Jul 30, 2026 | NYSE record cash equities +15% YoY; open interest +20% YoY; market data +10% users; "moderation in episodic volatility" | Mixed | High |
CME Q2 Earnings | Jul 22, 2026 | Equity complex ADV +13% YoY (June +54%); market data record +20% YoY; event contracts ADV +40% QoQ | Positive | Moderate-High |
NDAQ Conference | Jun 9, 2026 | Strong Apr–May options/equities activity; retail engagement strong; AI tailwind | Positive | Moderate |
ICE Conference | Jun 3, 2026 | Geopolitical uncertainty & rate repricing driving derivatives volumes; AI data demand strong | Positive | Moderate |
MKTX Q2 Earnings | Jul 30, 2026 | "Lower market volatility" in Q2; services/data revenue record +14% YoY | Mixed | Low-Moderate |
Key Takeaway: Only one insider transaction was disclosed in the post-Q1 window — a 10b5-1 planned sale by Director Janet P. Froetscher in May 2026. This is a pre-scheduled, obligation-driven transaction and carries no negative signal. No open-market discretionary buys or sells were filed, and no clustered selling activity was observed.
Name | Title | Transaction Type | Shares | Transaction Date | Filing Date | Note |
Froetscher, Janet P. | Director | 10b5-1 Planned Sale | 1,223 shares | May 18, 2026 | May 20, 2026 | Pre-scheduled 10b5-1 plan sale; obligation-driven, not discretionary. Remaining ownership: 13,807 shares. |
Source: SEC Form 4 Filings Database. Note: Transaction date (May 18) differs from Form 4 filing/disclosure date (May 20). No open-market discretionary buys or sells were filed by any CBOE insider in the May 1 – July 30, 2026 window. The absence of discretionary selling by senior management (CEO Craig Donohue, CFO Jill Griebenow, COO Scott Johnston) following the Q1 record results and raised guidance is a neutral-to-positive signal.